as of —
₹—
Change
—
Day Open
₹—
Day High
₹—
Day Low
₹—
NSE Close — 25 Sep 2026
₹41.09
Change
-0.18 (-0.44%)
Open
₹42.85
Prev. Close
₹41.27
Day High
₹42.85
Day Low
₹40.5
Volume Analysis
Traded
24,559
End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.
Strengths, Weaknesses, Opportunities & Threats
Strengths (1)
- •Promoter holding is rising
Weaknesses (0)
No signal for this stock
Opportunities (1)
- •Strong 3-year EPS growth (15.9%)
Threats (0)
No signal for this stock
Rule-based signals from the fundamentals below — not investment advice.
Pivot Levels
| Type | R3 | R2 | R1 | Pivot | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | ₹44.81 | ₹43.83 | ₹42.46 | ₹41.48 | ₹40.11 | ₹39.13 | ₹37.76 |
| Fibonacci | ₹43.83 | ₹42.93 | ₹42.38 | ₹41.48 | ₹40.58 | ₹40.03 | ₹39.13 |
| Camarilla | ₹41.74 | ₹41.52 | ₹41.31 | ₹41.48 | ₹40.87 | ₹40.66 | ₹40.44 |
Support/resistance levels for today, calculated from the previous trading day's high/low/close.
Absolute Returns
YTD
—
1 Week
+6.09%
1 Month
-6.63%
3 Months
+25.47%
6 Months
—
1 Year
—
2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.
Stock Vitals
Computed from the latest available annual financials.
Graham Number
₹32.87
Current price is above the Graham Number — Benjamin Graham's estimate of fair value based on earnings and book value.
DuPont ROE Breakdown
8.62%
Net margin 6.8% × asset turnover 0.72x × equity multiplier 1.76x
Company Overview
Sector
Healthcare
Market Cap
₹316 Cr
P/E (TTM)
22.2
ROE
12.4%
Book Value
₹20.7
Face Value
₹10.0
Source: Screener.in (Consolidated figures) — data as of 25 Sep 2026. Not investment advice.
TopFund Analysis
Ambalal Sarabhai Ent L lands in the middle of the pack on TopFund's composite fundamentals check within the Healthcare sector, at 53/100. The strongest factor is Financial Strength (96/100), while Liquidity (0/100) is the weakest area to weigh before deciding. Notably: Promoter holding is rising. Strong 3-year EPS growth (15.9%).
TopFund Score — Fundamentals Quality
53/100 — AverageData confidence: 78/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.
As of 27 Sep 2026 · How we calculate this →
Financial Strength
Growth
Valuation
Cash Flow
Corporate Governance
Momentum
Institutional Ownership
Business Quality
Risk & Volatility
Liquidity
From Screener.in
- −Though the company is reporting repeated profits, it is not paying out dividend
- −The company has delivered a poor sales growth of 4.35% over past five years.
- −Promoter holding is low: 31.4%
- −Tax rate seems low
Not investment advice — an automated read of public fundamentals data, for research context only.
Corporate Actions
We hereby submit Newspaper publication. Kindly take the same on your records.
Q1 FY27 consolidated snapshot: income Rs 45.59 crore, EBITDA Rs 6.57 crore, PBT Rs 4.68 crore.
Company clarifies no unpublished price-sensitive information; share price movement is market-driven.
Source: BSE regulatory filings, via Screener.in.
Quarterly Results
Last several quarters
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 36 | 40 | 43 | 54 | 41 | 45 | 46 | 65 | 40 | 44 | 52 | 65 | 44 |
| Expenses + | 40 | 39 | 41 | 50 | 40 | 42 | 47 | 60 | 39 | 44 | 48 | 60 | 39 |
| Operating Profit | -4 | 1 | 3 | 5 | 0 | 3 | -1 | 5 | 1 | 0 | 4 | 6 | 5 |
| OPM % | -11.0% | 2.52% | 5.87% | 8.56% | 1.15% | 5.68% | -1.52% | 8.18% | 3.62% | 0.81% | 7.85% | 8.7% | 10.45% |
| Other Income + | 1 | 3 | 2 | 5 | 2 | 3 | 6 | -5 | 8 | 2 | 2 | 3 | 2 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit before tax | -5 | 2 | 2 | 8 | 1 | 3 | 3 | -2 | 8 | 0 | 4 | 6 | 5 |
| Tax % | 5.87% | 40.0% | 34.31% | -8.69% | 59.52% | 15.76% | 23.89% | -86.83% | -3.66% | 1,300.0% | 16.51% | -4.0% | 14.96% |
| Net Profit + | -5 | 1 | 1 | 9 | 0 | 3 | 2 | 0 | 8 | -1 | 4 | 7 | 4 |
| EPS in Rs | -1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 1 |
| Raw PDF | — | — | — | — | — | — | — | — | — | — | — | — | — |
Source: Screener.in — figures in ₹ Crores unless marked %.
Profit & Loss (Yearly)
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 124 | 132 | 134 | 125 | 150 | 133 | 163 | 197 | 170 | 173 | 196 | 202 | 206 |
| Expenses + | 129 | 145 | 137 | 137 | 144 | 136 | 165 | 171 | 162 | 167 | 187 | 190 | 191 |
| Operating Profit | -4 | -13 | -3 | -12 | 6 | -3 | -2 | 25 | 8 | 6 | 9 | 12 | 15 |
| OPM % | -3.5% | -10.0% | -2.1% | -9.0% | 3.9% | -2.5% | -0.9% | 13.0% | 5.0% | 3.4% | 4.6% | 6.0% | 7.0% |
| Other Income + | 13 | 95 | -2 | 25 | 8 | 24 | 40 | 33 | 12 | 10 | 5 | 15 | 9 |
| Interest | 10 | 4 | 5 | 3 | 3 | 4 | 3 | 2 | 3 | 6 | 5 | 4 | 4 |
| Depreciation | 5 | 17 | 4 | 2 | 2 | 3 | 2 | 2 | 3 | 4 | 4 | 4 | 4 |
| Profit before tax | -6 | 62 | -14 | 8 | 8 | 15 | 33 | 54 | 15 | 7 | 5 | 19 | 15 |
| Tax % | 13.0% | 22.0% | 34.0% | 84.0% | 48.0% | 6.0% | 10.0% | 13.0% | 25.0% | 15.0% | -2.0% | 4.0% | — |
| Net Profit + | -7 | 48 | -18 | 1 | 4 | 14 | 29 | 47 | 11 | 6 | 5 | 18 | 14 |
| EPS in Rs | -1 | 6 | -2 | 0 | 1 | 2 | 4 | 6 | 1 | 1 | 1 | 2 | 2 |
| Dividend Payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
Source: Screener.in — figures in ₹ Crores unless marked %.
Balance Sheet
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reserves | -86 | -38 | -51 | -50 | -46 | -32 | -3 | 43 | 54 | 60 | 63 | 82 |
| Borrowings + | 46 | 47 | 42 | 43 | 40 | 31 | 28 | 27 | 45 | 46 | 51 | 57 |
| Other Liabilities + | 132 | 94 | 93 | 128 | 144 | 111 | 108 | 84 | 70 | 67 | 79 | 65 |
| Total Liabilities | 169 | 180 | 160 | 197 | 214 | 186 | 210 | 231 | 246 | 250 | 270 | 280 |
| Fixed Assets + | 91 | 72 | 72 | 59 | 58 | 57 | 57 | 58 | 85 | 88 | 87 | 89 |
| CWIP | 1 | 9 | 3 | 14 | 24 | 0 | 1 | 12 | 4 | 0 | 0 | 4 |
| Investments | 1 | 8 | 5 | 5 | 9 | 18 | 27 | 33 | 32 | 29 | 32 | 32 |
| Other Assets + | 76 | 92 | 80 | 119 | 123 | 110 | 125 | 128 | 125 | 133 | 151 | 155 |
| Total Assets | 169 | 180 | 160 | 197 | 214 | 186 | 210 | 231 | 246 | 250 | 270 | 280 |
| Equity Capital | 77 | 77 | 77 | 77 | 77 | 77 | 77 | 77 | 77 | 77 | 77 | 77 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Cash Flow
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | -8 | -75 | 5 | -7 | 19 | -7 | -2 | 11 | 6 | 9 | -18 | 13 |
| Cash from Investing Activity + | 10 | 80 | -3 | 18 | -9 | 17 | 10 | 5 | -17 | -5 | 13 | -10 |
| Cash from Financing Activity + | -1 | -3 | -6 | -2 | -6 | -14 | -6 | -19 | 9 | -3 | -2 | -2 |
| Net Cash Flow | 1 | 2 | -4 | 8 | 3 | -4 | 2 | -3 | -2 | 1 | -6 | 1 |
| CFO/OP | 90 | 551 | -252 | -107 | 453 | 134 | 22 | 60 | 120 | 217 | -160 | 107 |
| Free Cash Flow | 1 | 12 | 1 | 8 | 9 | -10 | 7 | 16 | -15 | 6 | -20 | 7 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Shareholding Pattern
Quarter-by-quarter — Promoters, FII, DII & public holding trend
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Public | 69.23% | 69.21% | 69.23% | 69.22% | 68.65% | 68.54% | 68.18% | 68.26% | 68.32% | 68.29% | 68.64% | 68.64% |
| Promoters | 30.78% | 30.78% | 30.78% | 30.78% | 31.35% | 31.35% | 31.35% | 31.35% | 31.35% | 31.36% | 31.36% | 31.36% |
| FII | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.38% | 0.38% | 0.34% | 0.34% | 0.0% | 0.0% |
| DII | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.1% | 0.1% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Source: Screener.in — quarterly shareholding disclosures.
Peers Comparison
Healthcare — ranked by market cap
| Company | Market Cap (Cr) | P/E | P/B | ROE |
|---|---|---|---|---|
| Ambalal Sarabhai Ent L (this stock) | 316 | 22.2 | 2.0 | 12.4% |
| Lyka Labs Ltd. | 310 | — | 3.31 | -10.2% |
| Nureca Limited | 335 | 77.3 | 1.86 | 1.12% |
| Qms Medical Allied S Ltd | 380 | 35.4 | 3.65 | 10.4% |
| Bilcare Ltd. | 232 | 11.7 | 1.22 | 1.39% |
| Take Limited | 229 | 38.9 | 7.38 | 16.5% |
| Nectar Lifesciences Ltd. | 211 | — | 0.36 | -31.3% |
Which Mutual Funds Hold Ambalal Sarabhai Ent L?
Frequently Asked Questions about Ambalal Sarabhai Ent L
Ambalal Sarabhai Ent L (AMBALALSA) closed at ₹41.09 on NSE on 25 September 2026, down 0.18 (0.44%) from the previous close.
Ambalal Sarabhai Ent L trades on the NSE (National Stock Exchange of India) under the symbol AMBALALSA.
Ambalal Sarabhai Ent L has a trailing twelve-month P/E (price-to-earnings) ratio of 22.2.
Ambalal Sarabhai Ent L has a dividend yield of 0.0%.
Ambalal Sarabhai Ent L's 52-week high is ₹50.0 and its 52-week low is ₹23.1.
Ambalal Sarabhai Ent L has a market capitalisation of ₹316 crore.
Ambalal Sarabhai Ent L has a TopFund Quality Score of 53/100 (Average), a composite of profitability, balance-sheet health, growth and valuation. This is an analytical score based on public data, not personalized investment advice — see the full breakdown below before deciding.
Community Sentiment
What are other investors saying about Ambalal Sarabhai Ent L?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
Sign in to join the discussionNo comments yet — start the discussion.